ISSN: 0213-005X

Indexed in:

Index Current Contents/Clinical Medicine, JCR, SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, CANCERLIT, SCOPUS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

2.6

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

2.1

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.355

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.381

View more metrics

Journal Information

Back to article

Statistics

Follow this link to access the full text of the article

Scientific letter

Case-fatality rates and risk of death from COVID-19 and influenza A/H3N2 in Brazil: A nationwide ecological study

Tasas de letalidad y riesgo de muerte por COVID-19 e influenza A/H3N2 en Brasil: un estudio ecológico a nivel nacional

Paulo Ricardo Martins-Filhoa,

Corresponding author

prmartinsfh@gmail.com

Corresponding author.

, Jerocílio Maciel de Oliveira Júniora, Cliomar Alves dos Santosb

a Health Sciences Graduate Program, Investigative Pathology Laboratory, Aracaju, Sergipe, Brazil

b Government of Sergipe State, Health Foundation Parreiras Horta, Central Laboratory of Public Health (LACEN/SE), Aracaju, Sergipe, Brazil

Read

667

Times
was read the article

Total PDF

579

Total HTML

Share statistics

Article information

ISSN: 0213005X
Original language: English

DOI:10.1016/j.eimc.2022.05.015

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 December	24	2	26
2024 November	43	2	45
2024 October	33	0	33
2024 September	45	6	51
2024 August	33	6	39
2024 July	33	2	35
2024 June	22	2	24
2024 May	26	1	27
2024 April	39	23	62
2024 March	50	6	56
2024 February	63	8	71
2024 January	30	3	33
2023 December	16	3	19
2023 November	31	1	32
2023 October	44	3	47
2023 September	9	3	12
2023 June	1	2	3
2023 April	3	3	6
2023 March	34	12	46

Show all

Follow this link to access the full text of the article

Publish in

Enfermedades Infecciosas y Microbiología Clínica

Free access articles

Outpatient parenteral antibiotic therapy (OPAT)...

Enferm Infecc Microbiol Clin. 2024;42:581-7

Corrigendum a: Ecografía clínica:...

Enferm Infecc Microbiol Clin. 2024;42:281

The current status of arboviruses with major...

Enferm Infecc Microbiol Clin. 2024;42:516-26

La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:

SOCIOS PROTECTORES

SOCIOS PATROCINADORES

- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.

Enfermedades Infecciosas y Microbiología Clínica follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter